Barrington Lifts PT on Haemonetics (HAE) to $50; Sees as Best Option for ARC Contract

January 30, 2014 10:47 AM

Barrington reiterates its Outperform rating and raises its price target on Haemonetics Corp. (NYSE: HAE) from $45 to $50 following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found